Development and validation of risk prediction and neural network models for dilated cardiomyopathy based on WGCNA
BackgroundDilated cardiomyopathy (DCM) is a progressive heart condition characterized by ventricular dilatation and impaired myocardial contractility with a high mortality rate. The molecular characterization of DCM has not been determined yet. Therefore, it is crucial to discover potential biomarke...
Main Authors: | Wei Yu, Lingjiao Li, Xingling Tan, Xiaozhu Liu, Chengliang Yin, Junyi Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1239056/full |
Similar Items
-
Integrated analysis of WGCNA and machine learning identified diagnostic biomarkers in dilated cardiomyopathy with heart failure
by: Yihao Zhu, et al.
Published: (2022-12-01) -
Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis
by: Qixin Guo, et al.
Published: (2022-08-01) -
Insight into the underlying molecular mechanism of dilated cardiomyopathy through integrative analysis of data mining, iTRAQ-PRM proteomics and bioinformatics
by: Hongli Xiong, et al.
Published: (2023-09-01) -
Bioinformatics Analysis of Common Differential Genes of Viral Myocarditis and Dilated Cardiomyopathy: Screening for Potential Pharmacological Compounds
by: Junyi Zhang, et al.
Published: (2022-10-01) -
Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
by: Huang G, et al.
Published: (2021-09-01)